Core Insights - ZimVie Inc. has become a privately held company following its acquisition by ARCHIMED, an investment firm focused on healthcare industries [1][2] - The acquisition involved ARCHIMED purchasing all outstanding shares of ZimVie stock at a price of $19.00 per share, leading to ZimVie's common stock being delisted from NASDAQ [2] Company Overview: ZimVie - ZimVie is a global leader in the dental implant market, developing and delivering a comprehensive range of products for dental tooth replacement and restoration [4] - The company is headquartered in Palm Beach Gardens, Florida, and aims to enhance smiles and confidence through its innovative dental solutions, including implants and digital workflows [4] Company Overview: ARCHIMED - ARCHIMED is a leading investment firm with a focus on healthcare industries, managing €8 billion across various funds [5] - The firm combines operational, medical, scientific, and financial expertise to support healthcare businesses in areas such as MedTech, Biopharma, and Diagnostics [5] - ARCHIMED is committed to impact investing and aims to help partners innovate and expand their services [5]
ZimVie Announces Completion of its Acquisition by ARCHIMED